QQ客服 官方微博 反馈留言

	Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis
	Sui, Wenhai; Li, Hongshi; Yang, Yunlong; Jing, Xu; Xue, Fei; Cheng, Jing; Dong, Mei; Zhang, Meng; Pan, Huazheng; Chen, Yuguo
刊名	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
	2019
卷号	116期号:22页码:10937-10942
关键词	mirabegron atherosclerosis plaque instability lipolysis adipose tissue
DOI	10.1073/pnas.1901655116
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4534646
专题	山东大学
作者单位	Shandong Univ, Key Lab Cardiovasc Remodeling & Fun
推荐引用方式 GB/T 7714	Sui, Wenhai,Li, Hongshi,Yang, Yunlong,et al. Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,2019,116(22):10937-10942.
APA	Sui, Wenhai.,Li, Hongshi.,Yang, Yunlong.,Jing, Xu.,Xue, Fei.,...&Zhan 更多.(2019).Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis.PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,116(22),10937-10942.
MLA	Sui, Wenhai,et al."Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis".PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 116.22(2019):10937-10942.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。